4//SEC Filing
RIKER LAUREN 4
Accession 0001628280-26-000967
CIK 0001396814other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:30 PM ET
Size
7.0 KB
Accession
0001628280-26-000967
Insider Transaction Report
Form 4
RIKER LAUREN
Senior Vice President, Finance
Transactions
- Tax Payment
Common Stock
2026-01-02$24.46/sh−159$3,889→ 60,480.242 total - Sale
Common Stock
2026-01-05$24.24/sh−1,416$34,324→ 59,064.242 total
Footnotes (3)
- [F1]Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
- [F2]Includes 1,075.242 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.
- [F3]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001545439
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:30 PM ET
- Size
- 7.0 KB